» Articles » PMID: 12757965

Changes in Patterns of Drug Injection Concurrent with a Sustained Reduction in the Availability of Heroin in Australia

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2003 May 22
PMID 12757965
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Between 1996 and 2000, heroin was the drug most frequently injected in Australia, and viable heroin markets existed in six of Australia's eight jurisdictions. In 2001, there was a dramatic and sustained reduction in the availability of heroin that was accompanied by a substantial increase in its price, and a 14% decline in the average purity of seizures analysed by forensic laboratories. The shortage of heroin constitutes a unique natural experiment within which to examine the impact of supply reduction. This paper reviews one important correlate of the shortage, namely changes in patterns of illicit drug injection. A number of studies have consistently suggested that between 2000 and 2001, there was a sizeable decrease in both prevalence and frequency of heroin injection among injecting drug users. These changes were accompanied by increased prevalence and frequency of stimulant injection. Cocaine was favoured in NSW, the sole jurisdiction in which a cocaine market was established prior to the heroin shortage; whereas methamphetamine predominated in other jurisdictions. Some data suggest that, at least in the short-term, some drug injectors left the market altogether subsequent to the reduced heroin availability. However, the findings that (1) some former heroin users switched their drug preference to a stimulant; and (2) subsequently attributed this change to the reduced availability of heroin, suggests that reducing the supply of one drug may serve to increase the use of others. Given the differential harms associated with the use of stimulants and opiates, this possibility has grave implications for Australia, where the intervention and treatment system is designed primarily to accommodate opiate use and dependence.

Citing Articles

'The Drugs Did For Me What I Couldn't Do For Myself': A Qualitative Exploration of the Relationship Between Mental Health and Amphetamine-Type Stimulant (ATS) Use.

Spencer L, Addison M, Alderson H, McGovern W, McGovern R, Kaner E Subst Abuse. 2021; 15:11782218211060852.

PMID: 34898985 PMC: 8655440. DOI: 10.1177/11782218211060852.


A rapid review of the impacts of "Big Events " on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19.

Zolopa C, Hoj S, Bruneau J, Meeson J, Minoyan N, Raynault M Int J Drug Policy. 2021; 92:103127.

PMID: 33549464 PMC: 7816610. DOI: 10.1016/j.drugpo.2021.103127.


Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?.

Salwan A, Hagemeier N, Harirforoosh S Clin Drug Investig. 2018; 38(7):573-577.

PMID: 29651781 DOI: 10.1007/s40261-018-0651-3.


Policing, massive street drug testing and poly-substance use chaos in Georgia - a policy case study.

Otiashvili D, Tabatadze M, Balanchivadze N, Kirtadze I Subst Abuse Treat Prev Policy. 2016; 11:4.

PMID: 26772817 PMC: 4715284. DOI: 10.1186/s13011-016-0049-2.


Perceived risk of methamphetamine among Chinese methamphetamine users.

Kelly B, Liu T, Yang X, Zhang G, Hao W, Wang J Int J Drug Policy. 2014; 25(6):1076-83.

PMID: 24925820 PMC: 4240772. DOI: 10.1016/j.drugpo.2014.05.007.